Aptevo Therapeutics Inc. - stock earnings
APVO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -5.9 million USD | ? USD |
| 2023Q3 | -6.3 million USD | ? USD |
| 2023Q2 | -7.9 million USD | ? USD |
| 2023Q1 | 11.4 million USD | ? USD |
| 2022Q4 | 30.4 million USD | -3.1 million USD |
| 2022Q3 | -7.7 million USD | ? USD |
| 2022Q2 | 63.4 million USD | ? USD |
| 2022Q1 | -10.0 million USD | 3.1 million USD |
| 2021Q4 | -6.3 million USD | 3.7 million USD |
| 2021Q3 | -7.0 million USD | 3.1 million USD |
| 2021Q2 | -7.9 million USD | 3.1 million USD |
| 2021Q1 | -7.3 million USD | 2.4 million USD |
| 2020Q4 | -7.1 million USD | 2.4 million USD |
| 2020Q3 | -6.8 million USD | 1.5 million USD |
| 2020Q2 | -6.8 million USD | 473000 USD |
| 2020Q1 | 2.9 million USD | 9.0 million USD |
| 2019Q4 | -8.2 million USD | 9.0 million USD |
| 2019Q3 | -6.9 million USD | 9.0 million USD |
| 2019Q2 | -13.3 million USD | 7.4 million USD |
| 2019Q1 | -12.0 million USD | 7.0 million USD |
| 2018Q4 | -14.1 million USD | 6.3 million USD |
| 2018Q3 | -12.6 million USD | 5.8 million USD |
| 2018Q2 | -13.1 million USD | 6.8 million USD |
| 2018Q1 | -13.9 million USD | 4.1 million USD |
| 2017Q4 | -9.8 million USD | 2.8 million USD |
| 2017Q3 | 37.9 million USD | 6.2 million USD |
| 2017Q2 | -11.2 million USD | 10.8 million USD |
| 2017Q1 | -9.9 million USD | 7.4 million USD |
| 2016Q4 | -14.9 million USD | 8.8 million USD |
| 2016Q3 | -71.7 million USD | 9.4 million USD |
| 2016Q2 | -12.8 million USD | 10.2 million USD |
| 2016Q1 | -11.8 million USD | 8.1 million USD |
| 2015Q4 | -17.9 million USD | 8.3 million USD |
| 2015Q3 | -12.7 million USD | 6.6 million USD |
| 2015Q2 | -17.7 million USD | 7.1 million USD |
| 2015Q1 | -11.0 million USD | 11.7 million USD |
| 2014Q4 | -51.1 million USD | 45.6 million USD |
APVO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.4 million USD | ? USD |
| 2022 | 42.7 million USD | 3.1 million USD |
| 2021 | -27.3 million USD | 12.3 million USD |
| 2020 | -18.4 million USD | 4.3 million USD |
| 2019 | -40.4 million USD | 32.4 million USD |
| 2018 | -53.7 million USD | 23.1 million USD |
| 2017 | 7.0 million USD | 14.7 million USD |
| 2016 | -112.4 million USD | 36.4 million USD |
| 2015 | -59.3 million USD | 33.6 million USD |
| 2014 | -51.1 million USD | 45.6 million USD |
| 2013 | -53.3 million USD | 170000 USD |
APVO
Price: $0.96
52 week price:
Earnings Per Share: -67.07 USD
P/E Ratio: -0.06
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 73389
Ebitda: -9.5 millionMarket Capitalization: 2.5 million